Cite
APA Citation
Lauss, M., Donia, M., Harbst, K., Andersen, R., Mitra, S., Rosengren, F., Salim, M., Vallon-Christersson, J., Törngren, T., Kvist, A., Ringnér, M., Svane, I., & Jönsson, G. (2017). mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nature communications, 8(1), 1–11. http://access.bl.uk/ark:/81055/vdc_100088086508.0x000072